Methylphenidate remains one of the most effective and widely used medications for ADHD across the world.

Yet, many patients — and even clinicians — are often confused about:

• Different formulations
• Duration of action
• Brand variations (India vs Western markets)

Understanding these differences is essential for individualising treatment.

What is Methylphenidate?

Methylphenidate is a central nervous system stimulant that works by:

• Increasing dopamine and norepinephrine availability
• Enhancing attention and executive functioning
• Reducing impulsivity and hyperactivity

It is considered a first-line treatment in ADHD across most international guidelines.

Why Formulations Matter

Not all methylphenidate is the same.

The key difference lies in:
👉 How fast it starts working and how long it lasts

This directly impacts:

• School/work performance
• Side effects
• Adherence
• Risk of rebound symptoms

1. Immediate Release (IR) – “Plain” Methylphenidate

Characteristics

• Onset: 20–40 minutes
• Duration: ~3–4 hours
• Requires: 2–3 doses/day

Advantages

• Flexible dosing
• Useful for titration
• Lower cost

Limitations

• Peaks and crashes
• Midday dosing required
• Compliance issues

Common Indian Brands

• Inspiral 5 mg / 10 mg (Sun Pharma)
• Addwize (varies by manufacturer)

Western Equivalent

• Ritalin

2. Sustained Release (SR)

Characteristics

• Onset: Slower than IR
• Duration: ~6–8 hours

Advantages

• Fewer daily doses
• Smoother effect than IR

Limitations

• Less flexible
• Variable absorption

Common Indian Brands

• Inspiral SR

Clinical Use

• School-going children
• Adults needing half-day coverage

3. Extended Release / OROS (Once-Daily Systems)

What is OROS?

OROS = Osmotic Controlled Release Oral System

It uses an advanced delivery system that:

• Releases medication gradually over the day
• Mimics multiple IR doses

Characteristics

• Onset: Gradual
• Duration: 10–12 hours

Advantages

• Once-daily dosing
• Stable plasma levels
• Minimal rebound

Limitations

• Higher cost
• Less flexible titration

Common Brands

• Concerta (globally known)
• Available in India (limited availability depending on supply chains)

4. Modified / Extended Release (Non-OROS Western Formulations)

Outside India, several advanced formulations exist:

Examples

• Ritalin LA
• Metadate CD
• Daytrana

Features

• Biphasic release (morning + afternoon dose simulation)
• Different release profiles tailored to lifestyle

Choosing the Right Formulation

Selection depends on:

Clinical Factors

• Severity of symptoms
• Duration of required coverage
• Comorbidities

Lifestyle Factors

• School vs office schedule
• Ability to take midday dose
• Risk of misuse

Practical Considerations

• Cost
• Availability
• Regulatory requirements

Indian Context: Practical Challenges

In India:

• Availability can be inconsistent
• Regulations require strict prescription control
• Not all formulations are easily accessible

This often leads to:

• Over-reliance on IR
• Suboptimal adherence

A Structured Approach Works Best

In clinical practice, an ideal approach is:

1. Start with IR formulation
2. Titrate dose based on response
3. Shift to SR / OROS for convenience and stability

This ensures:

• Accuracy
• Tolerability
• Better long-term outcomes

Key Takeaway

Methylphenidate is not a single drug —
it is a family of formulations with different clinical roles.

Understanding these differences allows:

• Better symptom control
• Fewer side effects
• Improved adherence

About the Author

Dr. Srinivas Rajkumar T, MD (AIIMS), DNB, MBA (BITS Pilani)
Consultant Psychiatrist & Neurofeedback Specialist
Mind & Memory Clinic, Apollo Clinic Velachery (Opp. Phoenix Mall)
✉ srinivasaiims@gmail.com 📞 +91-8595155808

With a clinical focus on ADHD, neurodevelopmental disorders, and technology-assisted psychiatry, Dr. Srinivas provides structured, evidence-based, and personalised treatment approaches tailored to Indian clinical realities